TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmor AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,682
|
2,980
|
2,796 |
Financial expenses |
317
|
437
|
585 |
Earnings before taxes |
1,605
|
924
|
1,095 |
EBITDA |
1,641
|
1,300
|
1,321 |
Total assets |
5,784
|
4,561
|
3,793 |
Current assets |
1,468
|
1,898
|
1,589 |
Current liabilities |
1,015
|
914
|
653 |
Equity capital |
4,340
|
3,291
|
2,834 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.0%
|
72.2%
|
74.7% |
Turnover per employee |
3,682
|
2,980
|
2,796 |
Profit as a percentage of turnover |
43.6%
|
31.0%
|
39.2% |
Return on assets (ROA) |
33.2%
|
29.8%
|
44.3% |
Current ratio |
144.6%
|
207.7%
|
243.3% |
Return on equity (ROE) |
37.0%
|
28.1%
|
38.6% |
Change turnover |
702
|
184
|
474 |
Change turnover % |
24%
|
7%
|
20% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.